XLRN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: XLRN Shares Outstanding History and XLRN YTD Return |
XLRN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: XLRN Shares Outstanding History and XLRN YTD Return |
XLRN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+42.24% CAGR Mouse over chart for data details
|
XLRN Stock Price Chart |
About Acceleron Pharma, Inc. |
Acceleron Pharma is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics to treat diseases. Co.'s research focuses on natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta, or TGF-beta, protein superfamily. By combining Co.'s discovery and development capabilities, including its proprietary knowledge of the TGF-beta superfamily, and its internal protein engineering and manufacturing capabilities, Co. generates therapeutic candidates, all of which encompass potential mechanisms of action. Co. has focused and prioritized its research and development activities within pulmonary and hematology. We show 34 historical shares outstanding datapoints in our XLRN shares outstanding history coverage, used to compute XLRN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XLRN market cap history over the course of time is important for investors interested in comparing XLRN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XLRN versus a peer is one thing; comparing XLRN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XLRN can fluctuate over the course of history. With this page we aim to empower investors researching XLRN by allowing them to research the XLRN market cap history. |
XLRN Current Stock Quote |
Free XLRN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
XLRN Share Performance |
Market Cap Peers |
Acceleron Pharma (XLRN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
XNCR Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.